References
- Gartoulla P, Worsley R, Bell RJ, Davis SR. Moderate-severe vasomotor and sexual symptoms remain problematic for 60-65 year old women. Menopause 2015;22:694–701
- Zeleke BM, Bell RJ, Billah B, Davis SR. Vasomotor and sexual symptoms in older Australian women: a cross-sectional study. Fertil Steril 2016;105:149–55 e141
- Gartoulla P, Bell RJ, Worsley R, Davis SR. Moderate-severely bothersome vasomotor symptoms are associated with lowered psychological general wellbeing in women at midlife. Maturitas 2015;81:487–92
- Gartoulla P, Bell RJ, Worsley R, Davis SR. Menopausal vasomotor symptoms are associated with poor self-assessed work ability. Maturitas 2016;87:33–9
- Worsley R, Bell RJ, Gartoulla P, Robinson PJ, Davis SR. Moderate-severe vasomotor symptoms are associated with moderate-severe depressive symptoms. J Women’s Health 2017;26:712–18
- Australian Burden of Disease Study. Impact and causes of illness and death in Australia 2011. Canberra: Australian Institute of Health and Welfare; 2016
- Davis SR, Lambrinoudaki I, Lumsden MA, et al. Menopause. Nat Rev Dis Primers 2015;1:15004
- Davis SR, Castelo-Branco C, Chedraui P, et al. Understanding weight gain at menopause. Climacteric 2012;15:419–29
- Stuenkel CA, Davis SR, Gompel A, et al. Treatment of symptoms of the menopause: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2015;100:3975–4011
- de Villiers TJ, Hall JE, Pinkerton JV, et al. Revised global consensus statement on menopausal hormone therapy. Climacteric 2016;19:313–15
- Manson JE, Kaunitz AM. Menopause management-getting clinical care back on track. N Engl J Med 2016;374:803–6
- Worsley R, Bell RJ, Gartoulla P, Davis SR. Low use of effective and safe therapies for moderate to severe menopausal symptoms: a cross-sectional community study of Australian women. Menopause 2016;23:11–17
- Nappi RE, Davis SR. The use of hormone therapy for the maintenance of urogynecological and sexual health post WHI. Climacteric 2012;15:267–74
- Gartoulla P, Davis SR, Worsley R, et al. Use of complementary and alternative medicines for menopausal symptoms in Australian women aged 40–65 years. Med J Aust 2015;203:146
- Rubinstein H. Defining what is normal at menopause: how women’s and clinician’s different understandings may lead to a lack of provision for those in most need. Hum Fertil 2014;17:218–22
- Collaborators Million Women's Study. Breast cancer and hormone replacement therapy in the Million Women Study. Lancet 2003;362:419–27
- Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials. JAMA 2013;310:1353–68
- Baber RJ, Panay N, Fenton A. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric 2016;19:109–50
- Morse JM. Qualitative generalizability. Qual Health Res 1999;9:5–6
- Berkman ND, Sheridan SL, Donahue KE, Halpern DJ, Crotty K. Low health literacy and health outcomes: an updated systematic review. Ann Intern Med 2011;155:97–107
- Bourke L, Humphreys JS, Wakerman J, Taylor J. Understanding rural and remote health: a framework for analysis in Australia. Health Place 2012;18:496–503
- Jane FM, Davis SR. A practitioner's toolkit for managing the menopause. Climacteric 2014;17:564–79
- Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006;3:77–101
- Liamputtong P, Qualitative research methods. 4th ed. South Melbourne, Vic.: Oxford University Press; 2013
- Castelo-Branco C, Peralta S, Ferrer J, Palacios S, Cornago S, Quereda F. The dilemma of menopause and hormone replacement-a challenge for women and health-care providers: knowledge of menopause and hormone therapy in Spanish menopausal women. Climacteric 2006;9:380–7
- Utian WH, Schiff I. NAMS-gallup survey on women’s knowledge, information sources, and attitudes to menopause and hormone replacement therapy. Menopause 2018;25:1172–9
- Lim HK, Mackey S. The menopause transition experiences of Chinese Singaporean women: an exploratory qualitative study. J Nurs Res 2012;20:81–9
- Cifcili SY, Akman M, Demirkol A, Unalan PC, Vermeire E. “I should live and finish it”: a qualitative inquiry into Turkish women’s menopause experience. BMC Fam Pract 2009;10:2
- Wambua LT. African perceptions and myths about menopause. East Afr Med J 1997;74:645–6
- Blumel JE, Castelo-Branco C, Kerrigan N, et al. Influences of hormone replacement therapy on postmenopausal women’s health perceptions. Menopause 2003;10:235–40
- Kingsberg SA, Krychman M, Graham S, Bernick B, Mirkin S. The Women’s EMPOWER Survey: identifying women’s perceptions on vulvar and vaginal atrophy and its treatment. J Sex Med 2017;14: 413–24
- Dietz NA, Mijares-Cantrell T, Acevedo D, et al. Women veterans and menopause: knowledge and preferences. Women Health 2018;58:898–914
- Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D. Pharmacological management of osteoporosis in postmenopausal women: an endocrine society* clinical practice guideline. J Clin Endocrinol Metab 2019;104:1595–622